Familial Polyposis and Colon Cancer

Area of Science:

• Genetics
• Oncology
• Gastroenterology

Background:

• Familial adenomatous polyposis (FAP) is a major hereditary risk factor for colorectal cancer.
• Patients and families with FAP require specialized care for prevention, early detection, and treatment.

Purpose of the Study:

• To review the key aspects of managing familial adenomatous polyposis.
• To highlight the importance of molecular testing, surveillance, and treatment strategies for FAP.

Main Methods:

• Review of current literature and clinical guidelines for FAP management.
• Discussion of genetic testing, colonoscopic surveillance, and chemoprevention options.
• Emphasis on both colonic and extracolonic manifestations.

Main Results:

• Molecular testing identifies the proband's mutation, facilitating risk assessment in family members.
• Aggressive surveillance, including frequent colonoscopies, is necessary for most FAP patients.
• Colectomy is often required for FAP management.

Conclusions:

• FAP necessitates a comprehensive management approach focusing on genetic identification, rigorous surveillance, and timely intervention.
• Understanding and addressing both colonic and extracolonic manifestations is vital.
• Chemoprevention strategies should be considered to potentially delay or reduce the need for surgery.